Emergent BioSolutions to Participate in Investor Conferences

On May 5, 2021 Emergent BioSolutions Inc. (NYSE: EBS) reported that members of the company’s senior management team will participate in the following investor conferences (Press release, Emergent BioSolutions, MAY 5, 2021, View Source [SID1234579188]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Goldman Sachs Credit and Leveraged Finance Conference
May 17, 2021
1-on-1 meetings only
Benchmark Company Healthcare House Call Conference
May 26, 2021
1-on-1 meetings only
Singular Research Spring Select Webcall
May 27, 2021
Company presentation scheduled at 8:00 am Pacific / 11:00 am Eastern
For conferences where a presentation is planned, the company’s webcast presentation may include a discussion of the company’s recent business developments as well as its financial results and guidance. The webcast will be available both live, if possible, and by replay, and will be accessible from the Emergent website.